ATE378327T1 - Substituierte cyclobutylaminderivate - Google Patents

Substituierte cyclobutylaminderivate

Info

Publication number
ATE378327T1
ATE378327T1 AT98921863T AT98921863T ATE378327T1 AT E378327 T1 ATE378327 T1 AT E378327T1 AT 98921863 T AT98921863 T AT 98921863T AT 98921863 T AT98921863 T AT 98921863T AT E378327 T1 ATE378327 T1 AT E378327T1
Authority
AT
Austria
Prior art keywords
derivatives
substituted
substituted cyclobutylamine
cyclobutylamine derivatives
cyclobutylamine
Prior art date
Application number
AT98921863T
Other languages
English (en)
Inventor
Makoto Takemura
Hisahi Takahashi
Kazuyuki Sugita
Rie Miyauchi
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE378327T1 publication Critical patent/ATE378327T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98921863T 1997-05-30 1998-05-28 Substituierte cyclobutylaminderivate ATE378327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14139897 1997-05-30

Publications (1)

Publication Number Publication Date
ATE378327T1 true ATE378327T1 (de) 2007-11-15

Family

ID=15291079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921863T ATE378327T1 (de) 1997-05-30 1998-05-28 Substituierte cyclobutylaminderivate

Country Status (20)

Country Link
US (1) US6448266B1 (de)
EP (1) EP0990654B1 (de)
JP (1) JP4357598B2 (de)
KR (1) KR100551462B1 (de)
CN (1) CN1191245C (de)
AR (1) AR012883A1 (de)
AT (1) ATE378327T1 (de)
AU (1) AU732175B2 (de)
BR (1) BR9809702A (de)
CA (1) CA2292580A1 (de)
DE (1) DE69838716T2 (de)
DK (1) DK0990654T3 (de)
ES (1) ES2297885T3 (de)
ID (1) ID23696A (de)
IL (1) IL133123A (de)
MY (1) MY119816A (de)
NO (1) NO318143B1 (de)
RU (1) RU2205829C2 (de)
WO (1) WO1998054169A1 (de)
ZA (1) ZA984527B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1264837C (zh) 1997-09-15 2006-07-19 普罗克特和甘保尔公司 喹诺酮抗微生物剂、其组合物和应用
HK1044476B (zh) 1999-03-17 2010-09-17 第一制药株式会社 药物组合物
PT1336611E (pt) * 2000-11-20 2007-12-06 Daiichi Sankyo Co Ltd Compostos desalogenados
AU2002230893B2 (en) 2000-12-14 2005-06-09 The Procter & Gamble Company Antimicrobial 2-pyridones, their compositions and uses
ATE304539T1 (de) 2000-12-14 2005-09-15 Procter & Gamble Antimikrobielle chinolone
WO2005030752A1 (ja) * 2003-09-29 2005-04-07 Daiichi Pharmaceutical Co., Ltd. 8−シアノキノロンカルボン酸誘導体
ES2366150T3 (es) 2006-03-28 2011-10-17 Warner Chilcott Company, Llc Malatos de polimorfos de ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinocarboxílico.
CA2647454A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
JPH0827728A (ja) * 1990-02-13 1996-01-30 Sf Marina System Ab ポンツーンの昇降案内装置
PT807630E (pt) * 1995-02-02 2003-08-29 Daiichi Seiyaku Co Compostos heterociclicos
JP3745433B2 (ja) * 1995-02-02 2006-02-15 第一製薬株式会社 複素環式化合物
JP4040091B2 (ja) * 1995-11-22 2008-01-30 第一三共株式会社 置換アミノシクロアルキルピロリジン誘導体

Also Published As

Publication number Publication date
KR20010013204A (ko) 2001-02-26
RU2205829C2 (ru) 2003-06-10
DE69838716D1 (de) 2007-12-27
ES2297885T3 (es) 2008-05-01
CN1265659A (zh) 2000-09-06
IL133123A0 (en) 2001-03-19
US6448266B1 (en) 2002-09-10
JP4357598B2 (ja) 2009-11-04
EP0990654B1 (de) 2007-11-14
NO318143B1 (no) 2005-02-07
AR012883A1 (es) 2000-11-22
EP0990654A4 (de) 2004-09-15
ID23696A (id) 2000-05-11
KR100551462B1 (ko) 2006-02-14
BR9809702A (pt) 2001-12-11
NO995839D0 (no) 1999-11-29
AU732175B2 (en) 2001-04-12
DK0990654T3 (da) 2008-01-21
DE69838716T2 (de) 2008-10-30
ZA984527B (en) 1998-12-03
IL133123A (en) 2005-12-18
EP0990654A1 (de) 2000-04-05
WO1998054169A1 (en) 1998-12-03
AU7453998A (en) 1998-12-30
CN1191245C (zh) 2005-03-02
MY119816A (en) 2005-07-29
CA2292580A1 (en) 1998-12-03
NO995839L (no) 2000-01-28

Similar Documents

Publication Publication Date Title
ATE235220T1 (de) Resorcinderivate
DK1005446T3 (da) N-aroylphenylalaninderivater
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
PT915088E (pt) Derivados de d-prolina
DK0973746T3 (da) Substituerede 3-cyanoquinoliner
DE69839398D1 (de) Pyridinderivate
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
PT1037892E (pt) Derivados de piperidina
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
ATE440854T1 (de) 5-deoxy-cytidin-derivate
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
PT869121E (pt) Derivados de propanolamina hipolipidemicos
ATE255099T1 (de) Substituierte chromanderivate
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DK0990654T3 (da) Substituerede cyclobutylaminderivater
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
ATE244705T1 (de) Substituierte 4-benzoyl-pyrazole
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
ID24079A (id) Aminoheteroksiklilamida tersubstitusi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties